Joseph H. Capper, Director at TELA Bio, Inc. (TELA), bought 75,000 shares at $1.17 ($89K) on 2026-09-16, disclosed to the SEC on 2026-09-18.
Director Joseph H. Capper purchased $58,265 worth of TELA Bio shares at $1.17, marking the largest insider purchase in the company's history. This significant accumulation comes as the stock has surged nearly 95% over the last 30 days, potentially signaling confidence in the recent turnaround.
TELA Bio has experienced explosive short-term momentum, rallying 32.63% over the last five days and 94.9% over the past month. Despite this surge, the stock remains significantly below its 52-week high of $1.685, trading at a 25.22% discount.
The next earnings report is scheduled for Q2 2026 on August 19, 2026, following a period of mixed results where revenue declined 4% while international sales surged 26%. Additionally, the company is executing a cost-reduction plan to extend its cash runway, a strategic focus highlighted in recent earnings calls.
The stock faces risks from recent analyst downgrades, including a price target cut to $2.25 on May 15, 2026, which contributed to a 10.0% share price drop. Furthermore, the company reported a Q2 2026 loss and a revenue miss of -3.55%, raising concerns about its ability to sustain growth.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.17 | 50,000 | $58K | 65.6% |
| 2 | $1.22 | 25,000 | $31K | 34.4% |
| Total | $1.18 avg | 75,000 | $89K | 100% |
| Filing → |
| MDXG | BUY | 2023-06-26 | $1.3M | — | Filing → |
| BEAT | SELL | 2018-07-30 | $32.4M | — | Filing → |
| BEAT | SELL | 2018-06-13 | $8.8M | — | Filing → |